Skip to main content
Characterization of Death Receptor 5 Targeting Nanoring Cancer Drugs
Palmatier, Katelyn (2012)
 

Title 
Characterization of Death Receptor 5 Targeting Nanoring Cancer Drugs

Author(s)

Issue Date
2012-04-18

Type
Presentation

Abstract
To maximize the effectiveness and minimize the adverse effects of chemotherapeutic agents, it is strategic to create drugs that specifically target cancer cells via ligand-receptor interactions. Several variations of a drug containing a ligand that binds to Death Receptor 5 were created and in vitro properties were characterized.

Appears in Collection(s)

Description
Faculty Advisor: Dr. Carston R. Wagner

Sponsorship
This research was supported by the Undergraduate Research Opportunities Program (UROP).

Suggested Citation
Palmatier, Katelyn. (2012). Characterization of Death Receptor 5 Targeting Nanoring Cancer Drugs. Retrieved from the University of Minnesota Digital Conservancy, http://purl.umn.edu/133312.


Content distributed via the University of Minnesota's Digital Conservancy may be subject to additional license and use restrictions applied by the depositor.